咨询与建议

限定检索结果

文献类型

  • 249 篇 期刊文献
  • 4 篇 会议

馆藏范围

  • 253 篇 电子文献
  • 0 种 纸本馆藏

日期分布

学科分类号

  • 111 篇 医学
    • 85 篇 临床医学
    • 57 篇 基础医学(可授医学...
    • 19 篇 药学(可授医学、理...
    • 8 篇 公共卫生与预防医...
  • 101 篇 理学
    • 63 篇 生物学
    • 12 篇 数学
    • 9 篇 物理学
    • 7 篇 化学
    • 5 篇 统计学(可授理学、...
    • 3 篇 天文学
  • 90 篇 工学
    • 36 篇 生物医学工程(可授...
    • 34 篇 计算机科学与技术...
    • 34 篇 软件工程
    • 29 篇 生物工程
    • 9 篇 光学工程
    • 6 篇 信息与通信工程
    • 4 篇 电气工程
    • 4 篇 电子科学与技术(可...
    • 3 篇 材料科学与工程(可...
    • 3 篇 控制科学与工程
    • 3 篇 化学工程与技术
    • 2 篇 力学(可授工学、理...
    • 2 篇 建筑学
    • 2 篇 土木工程
    • 2 篇 安全科学与工程
  • 27 篇 农学
    • 7 篇 作物学
  • 19 篇 管理学
    • 10 篇 管理科学与工程(可...
    • 5 篇 图书情报与档案管...
    • 4 篇 工商管理
    • 4 篇 公共管理
  • 2 篇 教育学
  • 1 篇 哲学

主题

  • 7 篇 pathology
  • 4 篇 cancer
  • 4 篇 diseases
  • 4 篇 tumors
  • 3 篇 computational bi...
  • 3 篇 machine learning
  • 3 篇 gene expression
  • 2 篇 human papillomav...
  • 2 篇 deep learning
  • 2 篇 generative adver...
  • 2 篇 image segmentati...
  • 2 篇 risk factors
  • 2 篇 cancer immunothe...
  • 2 篇 stage at diagnos...
  • 2 篇 genome-wide asso...
  • 2 篇 mortality
  • 2 篇 cervical cancer
  • 2 篇 epigenetic regul...
  • 2 篇 china
  • 2 篇 epigenetics

机构

  • 12 篇 cancer program b...
  • 11 篇 department of bi...
  • 11 篇 department of da...
  • 10 篇 department of in...
  • 10 篇 dana-farber canc...
  • 9 篇 department of bi...
  • 9 篇 department of me...
  • 8 篇 department of tw...
  • 8 篇 department of me...
  • 8 篇 department of pa...
  • 8 篇 broad institute ...
  • 7 篇 institute for ca...
  • 7 篇 department of mo...
  • 7 篇 department of pa...
  • 7 篇 cancer data scie...
  • 7 篇 department of pa...
  • 7 篇 harvard medical ...
  • 7 篇 data science pro...
  • 6 篇 national institu...
  • 6 篇 cancer program b...

作者

  • 26 篇 mahmood faisal
  • 20 篇 williamson drew ...
  • 19 篇 lu ming y.
  • 15 篇 chen tiffany y.
  • 14 篇 chen richard j.
  • 9 篇 jaume guillaume
  • 9 篇 lipkova jana
  • 8 篇 wei zheng
  • 7 篇 caroline hayward
  • 7 篇 song andrew h.
  • 6 篇 timothy m frayli...
  • 6 篇 danish saleheen
  • 6 篇 eleftheria zeggi...
  • 6 篇 mark i mccarthy
  • 6 篇 kari stefansson
  • 6 篇 macarthur daniel...
  • 6 篇 ezhov ivan
  • 6 篇 kofler florian
  • 6 篇 chen bowen
  • 6 篇 menze bjoern

语言

  • 246 篇 英文
  • 5 篇 其他
  • 2 篇 中文
检索条件"机构=Cancer Data Science Program"
253 条 记 录,以下是31-40 订阅
排序:
Phase I Study of Ixazomib Added to Chemotherapy in the Treatment of Acute Lymphoblastic Leukemia in Older Adults
收藏 引用
BLOOD 2020年 136卷 41-42页
作者: Amrein, Philip C. Ballen, Karen K. Stevenson, Kristen E. Blonquist, Traci M. Brunner, Andrew M. Hobbs, Gabriela S. Hock, Hanno R. McAfee, Steven L. Moran, Jenna A. Bergeron, Meghan Foster, Julia E. Bertoli, Christina McGregor, Kristin Macrae, Molly Burke, Meghan Behnan, Tanya T. Som, Tina T. Ramos, Aura Y. Vartanian, Megan K. Story, Jennifer Lombardi Connolly, Christine Graubert, Timothy A. Neuberg, Donna S. Fathi, Amir T. Leukemia Center/MGH Cancer Center Massachusetts General Hospital Belmont MA Division of Hematology/Oncology University of Virginia Health Center Charlottesville VA Department of Data Science Dana-Farber Cancer Institute Boston MA Data Science Dana-Farber Cancer Institute Boston MA Center for Leukemia Massachusetts General Hospital Boston MA Leukemia Center Massachusetts General Hospital Boston MA Leukemia Center Massachusetts General Hospital / Harvard Medical School Boston MA Massachusetts General Hospital Blood and Marrow Transplant Program Boston MA Leukemia Center Massachusetts General Hospital Center for Leukemia Cambridge MA
Introduction: While progress has been made in the treatment of childhood leukemia, the outlook for patients >60 years of age with acute lymphoblastic leukemia (ALL) is poor with complete remission rates (CR) of app...
来源: 评论
Choosing between HLA-Mismatched Unrelated and Haploidentical Donors: Donor Age Considerations
收藏 引用
Transplantation and Cellular Therapy 2025年 第2期31卷 S258-S259页
作者: Mehta, Rohtesh S., MD Wang, Tao, PhD Schmidt, Gabrielle, MPH Gadalla, Shahinaz M., MD, PhD Betts, Brian Christopher, MD Benjamin, Cara L., PhD Arrieta-Bolaños, Esteban, MQC, PhD Bolon, Yung-Tsi Lee, Stephanie J, MD, MPH Department of Stem Cell Transplantation and Cellular Therapy The University of Texas MD Anderson Cancer Center Houston TX CIBMTR® (Center for International Blood and Marrow Transplant Research) Medical College of Wisconsin Milwaukee WI Division of Biostatistics Data Science Institute Medical College of Wisconsin Milwaukee WI Center for International Blood and Marrow Transplant Research (CIBMTR) National Marrow Donor Program/Be The Match Minneapolis MN Clinical Genetics Branch; Division of Cancer Epidemiology and Genetics National Cancer Institute NIH Bethesda MD Roswell Park Comprehensive Cancer Center Buffalo NY Department of Medicine Univeristy of Miami Miller School of Medicine Miami FL Institute for Experimental Cellular Therapy University Hospital Essen Essen Düsseldorf Germany CIBMTR® (Center for International Blood and Marrow Transplant Research) NMDP Minneapolis MN Clinical Research Division Fred Hutchinson Cancer Center Seattle WA
BACKGROUNDHLA-mismatched unrelated donor (mmURD) and haploidentical donor (haplo) are the two most common mismatched donor options for hematopoietic cell transplantation (HCT). Substantial evidence suggests that donor...
来源: 评论
Whole slide images are 2D point clouds: Context-aware survival prediction using patch-based graph convolutional networks
arXiv
收藏 引用
arXiv 2021年
作者: Chen, Richard J. Lu, Ming Y. Shaban, Muhammad Chen, Chengkuan Chen, Tiffany Y. Williamson, Drew F.K. Mahmood, Faisal Department of Pathology Brigham and Women's Hospital Department of Biomedical Informatics Harvard Medical School Cancer Data Science Program Dana-Farber Cancer Institute Cancer Program Broad Institute of Harvard MIT
cancer prognostication is a challenging task in computational pathology that requires context-aware representations of histology features to adequately infer patient survival. Despite the advancements made in weakly-s... 详细信息
来源: 评论
Prognosis of Breast cancer in European female adolescents and young adults (AYAs): EUROCARE-6 retrospective cohort results
收藏 引用
The Breast 2025年 82卷
作者: Alice Bernasconi Angela Toss Emma Zattarin Seyed Mohsen Mousavi Marcel Blum Claudia E. Kuehni Alexander Katalinic Jan Trallero Elisabetta Rapiti Luigino Dal Maso Laura Botta Silvia Rossi Fedro Peccatori Annalisa Trama Evaluative Epidemiology Unit Department of Epidemiology and Data Science Fondazione IRCCS Istituto Nazionale dei Tumori Milan Italy Department of Oncology and Hematology Azienda Ospedaliero-Universitaria di Modena Modena Italy Department of Medical and Surgical Sciences University of Modena and Reggio Emilia Modena Italy Cancer Registry of Eastern Switzerland St.Gallen Switzerland Childhood Cancer Registry and Childhood Cancer Research Group Institute of Social and Preventive Medicine University of Bern Bern Switzerland Division of Pediatric Hematology/Oncology Inselspital Bern University Hospital University of Bern Bern Switzerland University of Lübeck Institute for Social Medicine and Epidemiology Lübeck Germany Cancer Registry of Girona Girona Spain Geneva Cancer Registry University of Geneva Geneva Switzerland Cancer Epidemiology Unit Centro di Riferimento Oncologico (CRO) IRCCS Aviano Italy Department of Oncology and Molecular Medicine Istituto Superiore di Sanità Rome Italy Gynaecology Oncology Program European Institute of Oncology IRCCS Milan Italy
Background Breast cancer (BC) is the most common malignancy in AYA (15–39 years) females and is more aggressive than in adult women (40–69 years). However, an updated overview on BC in AYAs and how it differs from B... 详细信息
来源: 评论
Comparative analyses for plant virus-based cancer immunotherapy drug development
Cell Biomaterials
收藏 引用
Cell Biomaterials 2025年
作者: Anthony O. Omole Hannah S. Newton Edward Cedrone Kimia Nematpour Shaojun Xie Yongmei Zhao Bao Tran Marina A. Dobrovolskaia Nicole F. Steinmetz Aiiso Yufeng Li Family Department of Chemical and Nano Engineering University of California San Diego La Jolla San Diego CA 92093 USA Shu and K.C. Chien and Peter Farrell Collaboratory University of California San Diego La Jolla San Diego CA 92093 USA Center for Nano-ImmunoEngineering University of California San Diego La Jolla San Diego CA 92093 USA Moores Cancer Center University of California San Diego La Jolla San Diego CA 92093 USA Nanotechnology Characterization Lab Cancer Research Technology Program Frederick National Laboratory for Cancer Research sponsored by the National Cancer Institute Frederick MD 21702 USA Sequencing Facility Bioinformatics Group Biomedical Informatics and Data Science Directorate Frederick National Laboratory for Cancer Research sponsored by the National Cancer Institute Frederick MD 21702 USA CCR Sequencing Facility Cancer Research Technology Program Frederick National Laboratory for Cancer Research sponsored by the National Cancer Institute Frederick MD 21702 USA Department of Bioengineering University of California San Diego La Jolla San Diego CA 92093 USA Department of Radiology University of California San Diego La Jolla San Diego CA USA Institute for Materials Discovery and Design University of California San Diego La Jolla San Diego CA 92093 USA Center for Engineering in Cancer Institute of Engineering Medicine University of California San Diego La Jolla San Diego CA 92093 USA
Cowpea mosaic virus (CPMV) is a plant virus with potent anti-tumor efficacy. Intratumoral CPMV, but not cowpea chlorotic mottle virus (CCMV), reprograms the tumor microenvironment priming durable, systemic anti-tumor ... 详细信息
来源: 评论
Treatment Outcomes By Duffy Genotype in Patients (Pts) with Newly Diagnosed Multiple Myeloma (NDMM) Receiving Lenalidomide, Bortezomib, and Dexamethasone (RVd) Alone or Rvd Plus Autologous Stem Cell Transplantation (ASCT) in the Determination Phase 3 Trial
收藏 引用
Transplantation and Cellular Therapy 2025年 第2期31卷 S406-S407页
作者: Merz, Lauren E., MD Zon, Rebecca L., MD Jacobus, Susanna J, MSc, MBA Samur, Mehmet K., PhD Zonder, Jeffrey, MD Khan, Dr. Abdullah Mohammad Hassoun, Hani, MD Anderson, Larry D., MD, PhD Efebera, Yvonne, MD Buck, Tondre, MD Shelton, Racquel D. Innis Hartley-Brown, Monique A., MD Lonial, Sagar, MD, FACP Campagnaro, Erica L., MD Voorhees, Peter M. Orlowski, Robert Z., MD, PhD Libby, Edward N., MD Hurd, David D, MD Costello, Caitlin, MD Raje, Noopur S., MD Medvedova, Eva, MD McCarthy, Philip L., MD Milner, Carter P., MD Gasparetto, Cristina, MD Agha, Mounzer E., MD Gowin, Krisstina, DO Kamble, Rammurti T., MD Jagannath, Sundar, MD Nathwani, Nitya, MD Alsina, Melissa, MD Giralt, Sergio A., MD Laubach, Jacob P., MD Nadeem, Omar, MD Ghobrial, Irene M., MD Mo, Clifton C., MD Anderson, Kenneth C., MD Munshi, Nikhil C., MD Richardson, Paul G., MD Department of Medical Oncology Dana-Farber Cancer Institute Harvard Medical School Boston MA Division of Hematology/Oncology Mass General Brigham Boston MA Department of Data Science Dana-Farber Cancer Institute Harvard Medical School Boston MA Barbara Ann Karmanos Cancer Institute / Wayne State University School of Medicine Detroit MI Division of Hematology The Ohio State University Comprehensive Cancer Center Columbus OH Myeloma Service Memorial Sloan Kettering Cancer Center New York NY Myeloma Waldenstrom's and Amyloidosis Program Simmons Comprehensive Cancer Center UT Southwestern Medical Center Dallas TX Division of Blood and Marrow Transplant/Hematology OhioHealth Columbus OH Gibbs Cancer Center & Research Institute Spartanburg SC Alabama Oncology University of Alabama at Birmingham Birmingham AL Winship Cancer Institute of Emory University Atlanta GA Division of Hematology and Oncology Department of Internal Medicine University of Michigan Ann Arbor MI Levine Cancer Institute Atrium Health Wake Forest University School of Medicine Charlotte NC Department of Lymphoma and Myeloma The University of Texas MD Anderson Cancer Center Houston TX Division of Medical Oncology University of Washington and Fred Hutchinson Cancer Center Seattle WA Section of Hematology and Oncology Atrium Health Wake Forest Baptist Medical Center Winston-Salem NC Moores Cancer Center at University of California San Diego San Diego CA Center for Multiple Myeloma Massachusetts General Hospital Harvard Medical School Boston MA
BackgroundErythrocyte Duffy null phenotype, seen in ∼66% of African American (AA) and 0, and pts with elevated LDH. Treatment duration was longer than in ITT pts: median duration from randomization (RVd-alone vs RVd+...
来源: 评论
Through the Lens of Patient Partners: Challenges in Accrual of Older Adults to NCI Clinical Trials
收藏 引用
Journal of the National cancer Institute - Monographs 2022年 第60期2022卷 125-134页
作者: BrintzenhofeSzoc, Karlynn Canin, Beverly Casas-Silva, Esmeralda Denicoff, Andrea Braun-Inglis, Christa Okado, Izumi Bakos, Alexis Oncology Social Work Kent School of Social Work University of Louisville Louisville KY United States SCOREboard Patient Advocate Board The Cancer and Aging Research Group United States Center for Biomedical Informatics and Information Technology Informatics and Data Science Program National Institutes of Health National Cancer Institute Rockville MD United States Division of Cancer Treatment and Diagnosis Cancer Therapy and Evaluation Program National Institutes of Health National Cancer Institute Rockville MD United States Clinical Faculty UH Nancy Atmospera-Walch School of Nursing University of Hawaii Cancer Center Hawaii M U NCORP Honolulu HI United States University of HawaiiCancer Center Honolulu HI United States Division of Cancer Prevention Community Oncology and Prevention Trials Research Group National Institutes of Health National Cancer Institute Rockville MD United States
The workshop “Engaging Older Adults in cancer Clinical Trials Conducted in the NCI Clinical Trials Network: Challenges and Opportunities” included a Patient Stakeholder Workgroup that explored the needs and concerns...
来源: 评论
Nivolumab plus low-dose ipilimumab in hypermutated HER2-negative metastatic breast cancer: a phase II trial (NIMBUS)
收藏 引用
Nature Communications 2025年 第1期16卷 1-13页
作者: Barroso-Sousa, Romualdo Zanudo, Jorge Gomez Tejeda Li, Tianyu Reddy, Sangeetha M. Emens, Leisha A. Kuntz, Thomas M. Silva, Carolina Alves Costa AlDubayan, Saud H. Chu, Hoyin Overmoyer, Beth Lange, Paulina DiLullo, Molly K. Montesion, Meagan Kasparian, Julie Hughes, Melissa E. Attaya, Victoria Basta, Ameer Lin, Nancy U. Tayob, Nabihah Jeselsohn, Rinath Mittendorf, Elizabeth A. Tolaney, Sara M. Hospital Brasília Rede Américas Brasilia Brazil Medical Oncology Dana-Farber Cancer Institute Boston MA United States Breast Oncology Program Dana-Farber Brigham Cancer Center Boston MA United States Harvard Medical School Boston MA United States Data Science Dana-Farber Cancer Institute Boston MA United States University of Texas Southwestern Medical Center Dallas TX United States University of Pittsburgh Medical Center Pittsburgh PA United States Department of Biostatistics Harvard T. H. Chan School of Public Health Boston MA United States Gustave Roussy Cancer Campus (GRCC) Clinicobiome Cedex Villejuif France Foundation Medicine Inc. Boston MA United States Division of Breast Surgery Department of Surgery Brigham and Women’s Hospital Boston MA United States
In the phase II NIMBUS trial, patients with human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer (MBC) and high tumor mutational burden (TMB ≥ 9 mut/Mb) received nivolumab (3 mg/kg biweek...
来源: 评论
Association of Risk Factors For Venous Thromboembolism and Overall Survival in Lung cancer
Blood Vessels, Thrombosis & Hemostasis
收藏 引用
Blood Vessels, Thrombosis & Hemostasis 2025年
作者: Thomas E. Plate Asaad Trabolsi Rachel S. Kronenfeld Leticia E. Campoverde Dan Morgenstern-Kaplan Alyssa J. Mercadel Michael Caballero Wei Zhao Gerald A. Soff Sylvester Comprehensive Cancer Center University of Miami Miller School of Medicine Miami Fl USA Hematology Oncology Fellowship Program Jackson Memorial Health System/ University of Miami Miami Fl USA Division of Pediatric Hematology/Oncology University of Miami/Jackson Memorial Hospital Miami FL Internal Medicine Residency program division of internal medicine Department of Medicine University of Miami/ Jackson Memorial Hospital Miami Division of Gynecologic Oncology Department of Obstetrics Gynecology and Reproductive Sciences University of Miami Leonard M. Miller School of Medicine Miami Data Science and Engineering UHealth Information Technology University of Miami Miami FL Biostatistics and Bioinformatics Shared Resource Sylvester Comprehensive Cancer Center University of Miami Miami FL Division of Hematology Department of Medicine University of Miami Miller School of Medicine Miami Fl USA
Venous thromboembolism (VTE) is a frequent complication in patients with lung cancer, but the risk factors and incidence in different lung cancer subtypes have not been fully characterized. Despite multiple studies su... 详细信息
来源: 评论
Roles of Cellular Neighborhoods in Hepatocellular Carcinoma Pathogenesis
收藏 引用
Pathology: Mechanisms of Disease 1000年 第1期20卷 169-192页
作者: Lichun Ma Cherry Caiyi Li Xin Wei Wang 2Liver Cancer Program Center for Cancer Research National Cancer Institute Bethesda Maryland USA 1Cancer Data Science Laboratory Center for Cancer Research National Cancer Institute Bethesda Maryland USA email: lichun.ma@nih.gov 3Laboratory of Human Carcinogenesis Center for Cancer Research National Cancer Institute Bethesda Maryland USA
The development of hepatocellular carcinoma (HCC) involves an intricate interplay among various cell types within the liver. Unraveling the orchestration of these cells, particularly in the context of various etiologi...
来源: 评论